Brief: Impel Neuropharma Says Trudhesa Nasal Spray Now Available For Prescription For Acute Treatment Of Migraine
28/09/2021 13:41
Sept 28 (Reuters) - Impel Neuropharma Inc IMPL.O :
* IMPEL NEUROPHARMA ANNOUNCES TRUDHESA™ (DIHYDROERGOTAMINE
MESYLATE) NASAL SPRAY IS NOW AVAILABLE FOR PRESCRIPTION FOR THE
ACUTE TREATMENT OF MIGRAINE
Source text for Eikon: ID:nGNX7mzBWq
Further company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq